Related Experiment Videos
Quantitation of the susceptibility difference between trabecular bone and bone marrow: experimental studies
S Majumdar1, D Thomasson, A Shimakawa
1Department of Radiology, University of California, San Francisco 94143.
Magnetic Resonance in Medicine
|November 1, 1991
Summary
Trabecular bone density significantly impacts magnetic resonance imaging (MRI) signal intensity by shortening the apparent relaxation time T2* due to magnetic field inhomogeneities. This effect, observed in vitro and in vivo, is crucial for understanding bone marrow imaging.
Area of Science:
- Biophysics
- Medical Imaging
- Materials Science
Background:
- Trabecular bone's susceptibility differences create magnetic field inhomogeneities.
- These inhomogeneities affect magnetic resonance (MR) signal intensity in gradient-echo images.
- Proton diffusion and transverse magnetization dephasing are key relaxation mechanisms.
Purpose of the Study:
- Quantify relaxation mechanisms affecting signal intensity in bone marrow with trabecular bone.
- Investigate the relationship between trabecular bone density and MR relaxation times (T1, T2, T2*).
- Differentiate susceptibility-induced relaxation from chemical-shift effects in bone marrow.
Main Methods:
- In vitro experiments using human vertebrae (varying bone densities) in saline or oil-water emulsion.
- Measurement of MR relaxation times T1, T2, and T2*.
- In vivo studies on normal volunteers to assess bone marrow relaxation rates in epiphysis and diaphysis.
Main Results:
- In vitro T1 and T2 showed no significant variation with bone density.
- In vitro relaxation rate (1/T2*) increased with bone density (0.2 s-1/mg/cc) due to susceptibility effects.
- In vivo, fat and water T2* were shorter in epiphysis than diaphysis, correlating with bone density variations.
Conclusions:
- Susceptibility-induced dephasing is the primary mechanism shortening T2* in trabecular bone.
- Bone density significantly influences T2* in bone marrow, impacting gradient-echo image signal intensity.
- In vivo findings confirm the influence of bone density on bone marrow T2* in different skeletal regions.